SEC Form 4 · accession 0001171843-15-001723
TETRALOGIC PHARMACEUTICALS Corp · TLOG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
J Kevin Buchi
Officer — President & CEO · Director
Period of report
Mar 26, 2015
Accepted (ET)
Mar 30, 2015 · 7:43 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001361248
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 26, 2015 | P | 5,000 | $4.2295 | A | 330,714 | D |
Table II — derivative securities
No Table II lines on this filing.